Peter Ahlering, MD, FACOG
Medical Director
Peter Ahlering, MD is reproductive specialist and medical director of MCRM Fertility. Dr. Ahlering is board-certified in Obstetrics and Gynecology and has been providing personalized fertility care for more than 20 years. Dr. Ahlering looks forward to the opportunity to assist you along your fertility journey.
Dr. Ahlering grew up following his father’s and two older brother’s footsteps by becoming an obstetrician. While a young physician, Dr Ahlering was emotionally impacted every time a patient suffered a pregnancy loss or fertility difficulties. As a result, he became determined to find ways to assist these patients have the families of their dreams. This lead Dr. Ahlering to specialize in reproductive care.
His research and career have led him to take a special interest in helping patients inflicted with recurrent pregnancy loss, male factor infertility, diminished ovarian reserve/ovarian aging and fertility preservation.
Accomplishments and Expertise
- 1989 - Graduate of the School of Medicine, University of Missouri - Kansas City
- 1993 -Chief Resident of Operative Laparoscopy and Reproductive Medicine, St. John’s Mercy Hospital – St. Louis
- Fellow of the American Congress of Obstetricians and Gynecologists
- Consultant editor, "Practical Guide to High Risk Pregnancy and Delivery, 2nd Edition
- Recognized, multiple times, as a Castle Connolly Top Doctors®
- Recognized, multiple times, as the "Best Fertility Physician"
- Contributor to TLC’s “A Conception Story”
- Contributor to multiple scientific research studies/literature
- Nano Particle Sperm Enrichment with Improved Fertility Rates
- Biomarker-Based Flow Cytometric Semen Analysis for Male Infertility Diagnostics and Clinical Decision Making in ART
- Sperm Chromatin Structure Correlates with Spontaneous Abortion and Multiple Pregnancy Rates in Assisted Reproduction
- The Role of In Vitro Fertilization in the Setting of Recurrent Miscarriage
- Correlation between Neutral Alpha-Glucosidase Activity and Sperm DNA Fragmentation
- The INVOcell, a New Medical Device for Intra-vaginal Fertilization and Culture
- Soluble Human Leukocyte Antigen G Expression in Phase I Culture Media at 46 hours after Fertilization Predicts Pregnancy and Implantation from Day 3 Embryo Transfer
- Influence of Early ICSI-derived Embryo sHLA-G Expression on Pregnancy and Implantation Rates: a prospective study
- The Sperm DNA Integrity Assay (SDITM) a Valuable Method for Assessing Sperm Vitality in Preparation for In Vitro Fertilization
To schedule an initial consultation with Dr. Ahlering or to learn more about MCRM Fertility call 844-41-4BABY.